Contemporary Management of and Future Directions in Ovarian Cancer
Medical Editor Robert L. Coleman, MD
Professor and Director, Clinical Research
Department of Gynecologic Oncology
University of Texas, M.D. Anderson Cancer Center
Houston, Texas
Supported by an educational grant from Genentech BioOncology 2 AMA PRA Category 1 Credits™
Authors Part 1 Robert A. Burger, MD
Professor, Department of Surgical Oncology
Section of Gynecologic Oncology
Director, Women’s Cancer Center
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Part 2 Thomas Herzog, MD
Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Columbia University
Herbert Irving Cancer Center
New York, New York
The goal of this activity is to clarify challenging treatment issues of HER2+ breast cancer including incorporation of predictive and prognostic biomarker tests and evidence-based data into practice when determining individualized strategies that improve patient survival and quality of life.